Artificial Intelligence-enabled Large-scale Electrocardiogram Feature Extraction and Exploring Association Between the Extracted Features and Mortality, Stroke or Various Health Outcome of Interest
NCT ID: NCT06179849
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
3000000 participants
OBSERVATIONAL
2023-12-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Intended to use a web-based artificial intelligence platform to distribute computational loads generated during large-scale data processing and improve analysis accuracy and efficiency.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
NCT07347691
Evaluation of Clinical Intelligence Support to Reduce Errors in Normal ECGs
NCT07179185
AI-ECG Screening for Left Ventricular Systolic Dysfunction
NCT06231797
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms
NCT05117970
Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up
NCT06924580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Research Methods:
1. Electrocardiogram extraction based on the criteria of subjects.
2. Combined with extracted ECG data and National Insurance Corporation data (+ National Statistical Office cause of death data).
3. Health out of interest (HOI) definition. Includes death, stroke, etc.
4. The defined HOI can be extracted from Yonsei Medical Center data or from National Insurance Service data or Statistics Korea's cause of death data.
5. Artificial intelligence model training with electrocardiogram (and clinical information diagram if necessary) as input, utilizing supervised deep learning algorithms if there is a label and unsupervised learning algorithms if there is no label.
6. Performance evaluation for supervised learning artificial intelligence models.
7. In the case of unsupervised learning artificial intelligence models, the association/correlation between extracted features and HOI or predictability/detectability analysis.
8. Transfer learning can be performed by adding external verification or dielectric data to the learned model using public databases.
9. External verification can be performed using external additional data by mounting the learned model on a web-based artificial intelligence platform.
10. Considering large-scale data, computing workloads can be distributed using web-based artificial intelligence platforms.
11. The analysis results can be anonymized and the analysis results can be provided to researchers through a web-based artificial intelligence platform.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hui-Nam Pak
Role: PRINCIPAL_INVESTIGATOR
Yonsei University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yonsei University Health System
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2022-1506
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.